Amyris Inc at Jefferies Consumer Conference (Virtual) Transcript
Okay. Thank you, guys, for joining us and welcome to the Amyris fireside chat with President and CEO, John Melo. I am Edlain Rodriguez from the Jefferies chemicals team. So without further ado, let's get started.
So, John, Amyris has one of the longest histories in synthetic biology, and you are flagged being capable of producing more than 250 molecules from 15 chemical families and over 20 biological pathways. But how would you differentiate Amyris' core approach from companies such as DSM, Genematics, Ginkgo? Like, what are the trade-offs for vertical integration all the way to the consumer brands?
Great. First of all, Edlain, very nice to be on this with you, and appreciate the invitation. Look, I'd say it's interesting, the names of the companies you just chose. Because I think some of them are academic, talking about a vision they haven't yet executed. And others are really significant, fantastic at synthetic biology and really very
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |